AI-assisted, human-published
12/11/2024 /Funding Events
Veradermics Closes $75M Series B Financing for Dermatology Therapeutics
Veradermics successfully concludes $75M Series B financing led by Suvretta Capital Management, to support the development of their lead candidate VDPHL01 for androgenetic alopecia treatment.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com